MicroRNA dysregulation to identify therapeutic target combinations for chronic lymphocytic leukemia.

about

MicroRNA dysregulation to identify therapeutic target combinations for chronic lymphocytic leukemia.

Item

http://www.wikidata.org/entity/Q46103134

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

MicroRNA dysregulation to iden ...... chronic lymphocytic leukemia.

@en

MicroRNA dysregulation to iden ...... chronic lymphocytic leukemia.

@nl

type

Item

label

MicroRNA dysregulation to iden ...... chronic lymphocytic leukemia.

@en

MicroRNA dysregulation to iden ...... chronic lymphocytic leukemia.

@nl

prefLabel

MicroRNA dysregulation to iden ...... chronic lymphocytic leukemia.

@en

MicroRNA dysregulation to iden ...... chronic lymphocytic leukemia.

@nl

P1476

MicroRNA dysregulation to iden ...... chronic lymphocytic leukemia.

@en

P2093

Alexey Palamarchuk

http://www.w3.org/2001/XMLSchema#string

Emanuela M Ghia

http://www.w3.org/2001/XMLSchema#string

George F Widhopf

http://www.w3.org/2001/XMLSchema#string

Laura Z Rassenti

http://www.w3.org/2001/XMLSchema#string

Luisa Tomasello

http://www.w3.org/2001/XMLSchema#string

Paolo Fadda

http://www.w3.org/2001/XMLSchema#string

Thomas J Kipps

http://www.w3.org/2001/XMLSchema#string

Veronica Balatti

http://www.w3.org/2001/XMLSchema#string

Yuri Pekarsky

http://www.w3.org/2001/XMLSchema#string

P2860

The Wingless homolog WNT5A and its receptor Frizzled-5 regulate inflammatory responses of human mononuclear cells induced by microbial stimulation

Antisera induced by infusions of autologous Ad-CD154-leukemia B cells identify ROR1 as an oncofetal antigen and receptor for Wnt5a

miR-15 and miR-16 induce apoptosis by targeting BCL2

Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia

MiR-15a and miR-16-1 cluster functions in human leukemia

Pre-clinical Specificity and Safety of UC-961, a First-In-Class Monoclonal Antibody Targeting ROR1

ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets

MicroRNA signatures in human cancers

Secondary mutations as mediators of resistance to targeted therapy in leukemia

Genomic aberrations and survival in chronic lymphocytic leukemia

P304

10731-10736

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1708264114

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

114

http://www.w3.org/2001/XMLSchema#string

P50

Carlo Maria Croce

P577

2017-09-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28923920

http://www.w3.org/2001/XMLSchema#string

P921

lymphocyte

P932

5635897

http://www.w3.org/2001/XMLSchema#string